Could zapping the brain lift mood in Parkinson's?
NCT ID NCT03131817
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether stimulating the front part of the brain could improve mood and behavioral symptoms in people with Parkinson's disease. Five participants received a special brain device that could record and stimulate brain activity. The goal was to see if this approach could help with depression, anxiety, and motivation. The study was very small and early, so results are not conclusive.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Medtronic Activa PC+S brain stimulation device
- What this could lead to
- If successful, this could point toward a new way to treat mood and behavioral symptoms in Parkinson's disease using brain stimulation.
- What could go wrong
- This was a very small, early study with only 5 participants, so results may not apply to everyone. The approach is still experimental and needs much larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
5 people
The number who actually took part.
- Started
-
Dec 2016
- Finished
-
Jun 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Ability to give informed consent for the study * Age 30-75 * Diagnosis of Parkinson's disease by a movement disorders specialist * Movement disorder symptoms that are sufficiently severe, in the setting of best medical therapy, to warrant surgical implantation of deep brain stimulators according to standard clinical criteria * UPDRS-III score off medication between 20 and 80 and an improvement of at least 30% in the baseline UPDRS-III on medication score, compared to the baseline off-medication score. OR Patients with tremor-dominant PD (a tremor score of at least 2 on a UPDRS-III sub-score for tremor), treatment resistant, with significant functional disability despite maximal medical management OR Patients intolerant to medication causing significant functional disability * Have one or several mild to moderate mood or impulsive behavior as defined by: 1. depression (BDI\>=13) 2. anxiety (BAI \>=7) 3. impulsive behavior as indicated by a positive score on the Questionnaire for Impulsive-Compulsive disorders in Parkinson's Disease (QUIP-A) or as determined by clinical interview or informant report 4. Mood or behavior symptom fluctuations corresponding to minimum 30% improvement in non-motor symptoms when comparing visual analogue scales (VAS) scores in the on versus off medication state * Stable doses of anti-Parkinsonian medications for at least 30 days prior to their baseline assessment. Exclusion Criteria: * Pregnancy or breast feeding * MRI showing cortical atrophy out of proportion to age * MRI showing focal brain lesions that could indicate a disorder other than idiopathic PD * Major comorbidity increasing the risk of surgery (prior stroke, severe hypertension, severe diabetes, or need for chronic anticoagulation other than aspirin) * Any prior intracranial surgery except DBS surgery * Significant cognitive impairment (MoCA\<20). * History of seizures * Immunocompromised * Has an active infection * Requires diathermy, electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS) to treat a chronic condition * Inability to comply with study follow-up visits * Any personality or mood symptoms that study personnel believe will interfere with study requirements.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Parkinson's disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UCSF Surgical Movement Disorders Center
San Francisco, California, 94115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Walking memory tests may reveal early Parkinson's clues
- Colon tissue may hold clues to telling Parkinson's apart from Look-Alike diseases
- A genetic roadmap for Parkinson's: testing thousands to unlock clues
- Can gentle touch therapy calm Parkinson's tremors?
- Stem cell infusions aim to slow Parkinson's progression
- Can an inhaled levodopa ease Parkinson's OFF episodes? a study asks patients.